Style | Citing Format |
---|---|
MLA | Amani B, et al.. "Comparative Efficacy and Safety of Nirmatrelvir/Ritonavir and Molnupiravir for Covid-19: A Systematic Review and Meta-Analysis." Journal of Medical Virology, vol. 95, no. 6, 2023, pp. -. |
APA | Amani B, Akbarzadeh A, Amani B, Shabestan R, Khorramnia S, Navidi Z, Rajabkhah K, Kardanmoghadam V (2023). Comparative Efficacy and Safety of Nirmatrelvir/Ritonavir and Molnupiravir for Covid-19: A Systematic Review and Meta-Analysis. Journal of Medical Virology, 95(6), -. |
Chicago | Amani B, Akbarzadeh A, Amani B, Shabestan R, Khorramnia S, Navidi Z, Rajabkhah K, Kardanmoghadam V. "Comparative Efficacy and Safety of Nirmatrelvir/Ritonavir and Molnupiravir for Covid-19: A Systematic Review and Meta-Analysis." Journal of Medical Virology 95, no. 6 (2023): -. |
Harvard | Amani B et al. (2023) 'Comparative Efficacy and Safety of Nirmatrelvir/Ritonavir and Molnupiravir for Covid-19: A Systematic Review and Meta-Analysis', Journal of Medical Virology, 95(6), pp. -. |
Vancouver | Amani B, Akbarzadeh A, Amani B, Shabestan R, Khorramnia S, Navidi Z, et al.. Comparative Efficacy and Safety of Nirmatrelvir/Ritonavir and Molnupiravir for Covid-19: A Systematic Review and Meta-Analysis. Journal of Medical Virology. 2023;95(6):-. |
BibTex | @article{ author = {Amani B and Akbarzadeh A and Amani B and Shabestan R and Khorramnia S and Navidi Z and Rajabkhah K and Kardanmoghadam V}, title = {Comparative Efficacy and Safety of Nirmatrelvir/Ritonavir and Molnupiravir for Covid-19: A Systematic Review and Meta-Analysis}, journal = {Journal of Medical Virology}, volume = {95}, number = {6}, pages = {-}, year = {2023} } |
RIS | TY - JOUR AU - Amani B AU - Akbarzadeh A AU - Amani B AU - Shabestan R AU - Khorramnia S AU - Navidi Z AU - Rajabkhah K AU - Kardanmoghadam V TI - Comparative Efficacy and Safety of Nirmatrelvir/Ritonavir and Molnupiravir for Covid-19: A Systematic Review and Meta-Analysis JO - Journal of Medical Virology VL - 95 IS - 6 SP - EP - PY - 2023 ER - |